Clinical Trial Information Request for Protocol 24-433 Title PRIMAVERA: A Modular Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of AZD3470, a PRMT5 Inhibitor as Monotherapy or in Combination with Anticancer Agent(s) in Participants with Relapsed/Refractory Haematologic Malignancies PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone